Athenex, Inc. announced the resignation of Sheldon Trainor-De Girolamo as a Director of the company. The company also announced the appointment of two new Directors: John Moore Vierling, MD, FACP, FAASLD, AGAF and Stephanie Davis. Dr. John Moore Vierling is also Director of Advanced Liver Therapies, Baylor Liver Health and Program Director of the Hepatology and Liver Transplantation Fellowship. Ms. Stephanie Davis is a Senior Client Partner at Korn Ferry, and leads the Private Equity and Technology markets in North America and is a core member of the CEO and Board practices. She brings over 20 years of leadership consulting experience, working with CEOs to build their executive teams and with Boards of Directors on governance, diversity and succession planning.